SEATTLE, May 10, 2021, (MEDGADGET) — Global Corona Virus (COVID-19) Vaccines Market analysis
The most recent outbreak of coronavirus disease (COVID-19) was first reported in Wuhan City, China on December 31, 2019. In March 2020, the World Health Organization (WHO) had declared the coronavirus disease (COVID-19) as a global pandemic. Caused by a coronavirus member called SARS-CoV-2, COVID-19 is a viral infection which affects the respiratory tract. With high infection rate, the COVID-19 virus gets transmitted by direct contact with the infected person or through an indirect contact with the surfaces of a surrounding. Furthermore, the transmission rate of COVID-19 virus has dynamically increased among the people, which has made it a global epidemic. As per the World Health Organization’s COVID-19 Weekly Epidemiological Update, over 57.8 million cases and around 1.3 million deaths have occurred due to COVID-19 as of November 22, 2020 globally.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4320
The soaring prevalence of COVID-19 globally has uttered the urgent requirement of COVID-19 vaccines to control the transmission and battle this pandemic situation. As per the World Health Organization (WHO), about 48 vaccines are undergoing evaluations clinically, out of which only 10 vaccines are in the third phase of clinical trials.
Furthermore, various healthcare organizations are getting funded globally due to their distribution rights of coronavirus vaccine after the regulatory authorities will grant them the approval for production of the doses. On October 13, 2020, the World Bank had approved a total of US$ 12 billion to developing economies in order to finance the testing, purchase, distribution, and treatment of the COVID-19 vaccine.
Market Segmentation
As per the type of vaccine: Repurposed Vaccines, Inactivated Virus, RNA Vaccine, Protein Subunit, DNA Vaccine, Non-replicating Viral Vector, and Genetic Vaccine.
The global coronavirus vaccine market is expected to propel a CAGR of 30.9% over the forecast period (2021-2027) and is estimated to be worth around US$ 14.5 billion in 2021.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4320
Drivers
Booming cases of COVID-19 are expected to boost growth of the global coronavirus vaccines market over the forecast period.
Rising number of COVID-19 cases has surged the demand for vaccines, which is expected to propel growth of the global coronavirus market during the forecast period. As per the World Health Organization’s COVID-19 Weekly epidemiological update, various regions have reported the COVID-19 cases as of November 22, 2020 are as follows:
Increased activities of research and development for COVID-19 vaccine is expected to stimulate the market growth over the forecast period.
Due to outbreak of the pandemic, the demand for COVID-19 vaccine has increased globally, which is expected to boost growth of the global coronavirus vaccine market over the forecast period. In November 2020, Moderna Inc., had announced that the trial of its vaccine candidate Mrna-1273 which is in Phase 3, has shown the efficacy of 94.5% against COVID-19. Furthermore, on November 25, 2020, the European Commission came into an agreement with Moderna Inc., to buy around 160 million doses of their potential vaccine for COVID-19.
Restraint
Obstructions in the approval and launch of COVID-19 vaccines due to rigorous regulations imposed by several regulatory authorities, is expected to hamper growth of the global coronavirus vaccine market during the forecast period.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4320
Key Players
Key players contributing in the global coronavirus vaccine market are Cadila Healthcare Limited, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, Symvivo, Johnson & Johnson, BioNTech SE, Serum Institute of India, Bharat Biotech International Limited, Shanghai Fosun Pharmaceutical Group Co., Ltd., CanSino Biologics Inc., CureVac AG, AstraZeneca plc, Pfizer Inc., Sanofi S.A., Novavax, Inc., Moderna, Inc., and Sinovac Biotech Ltd.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- New Vaccine Type Approvals/Launch
- Promotion and Marketing Initiatives
- PEST Analysis
- Global Corona Virus Vaccine Market, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Inactivated Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Protein Subunit
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Non-replicating Viral Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Repurposed Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- RNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Genetic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Corona Virus Vaccine Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/corona-virus-vaccines-market-3581
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837